BiomedReports: Encouraging Phase III Results for ARCA Biopharma, Inc.

BioMedReports, the news portal covering the biomedical news and financial sector is tracking ARCA biopharma, Inc. (ARCA), formerly Nuvelo, Inc. as their lead product candidate Gencaro is under review by the United States Food and Drug Administration (FDA), for chronic heart failure (HF). - May 14, 2009

FDA Calendar Updates for AZN, MIPI, MELA, IMGN

FDA Calendar Updates for AZN, MIPI, MELA, IMGN

While there are still significant upside catalysts for the stock starting with the finalization of the pixantrone NDA filing in June and priority review ruling by the FDA, the risk/reward is drastically different at current levels compared to a earlier reports. - May 12, 2009

BiomedReports: Cell Therapeutics' Turnaround Remains on Track

Biomedical news portal profiles a company that received $20.5M in gross proceeds earlier this year from Spectrum Pharma (SPPI). - May 10, 2009

First Ever Drug from Genetically Modified Animals Goes to Market

Milk product will be used for the prevention of blood clots in patients with a rare disease. - May 08, 2009

BiomedReports: Bionic Arms Race Produces Extremely Tangible Results

See a new bionic arm that can do everything from picking up a grape without smooshing it to tossing a ball to reaching for an item on a high shelf. - May 04, 2009

Investors Experience a Gut Level Response to Financial Losses

If watching your financial investments lose money has made you sick to your stomach, there may be a very good reason for that. How you handle financial loss may be having a direct biological response in your brain and stomach according to a new video report on the biomedical stock news website... - May 02, 2009

Investors Seeking FDA Decision and Clinical Trial News Flock to

FDA Calendar, unbiased reporting on emerging biotech sector now available at news portal created by and for investors and traders. - May 01, 2009 Swine Flu Virus Hits the Markets

Shares of niche makers of antiviral products and vaccines saw shares rocket in early trading Monday on news that the world could be facing a global pandemic of the swine flu virus. Concerns about the growing health crisis helped boost drug stocks for Biota Holdings Ltd., with U.S.-traded shares... - April 29, 2009

BiomedReports: Allos Therapeutics - A Small-Cap Cancer Biotech with an FDA Catalyst today is unveiling coverage on Allos Therapeutics, a promising small-cap cancer biotech with the potential for an upcoming FDA approval decision. - April 29, 2009

BiomedReports: FDA, Clinical Trial Updates for Pro-Pharma, Theravance, Johnson & Johnson

FDA Decisions & Clinical Trial Results Move the Bio Market - Make Informed Decisions with Solid, No-Hype Analysis & Valuable Industry News about companies with pending FDA decisions and Clinical Trial at - April 28, 2009

Press Releases 1 - 10 of 10